S
Sage Therapeutics (SAGE)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Sage Therapeutics (SAGE)
SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenou... Read more
- USD6.97
- USD7.00
- USD6.70
- USD13.47
- 5.00%
- 47M
- 3.00
- 917.04k
- 457M
- 4.62
- -45.80%
Stock News
7 hours ago
Rivian: Near-Term Deliveries Cut Has No Bearing On R2's Future
SeekingAlpha
7 hours ago
Rates Spark: Market Discount Shifts To Un-Discounting Some Recession Risks
SeekingAlpha
7 hours ago
Uber: Accelerates AV Ambitions As Growth Shows Signs Of Stalling
SeekingAlpha
7 hours ago
The Next Frontier In Portfolio Design: Keeping Equities While Adding Gold
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
